Ratings SunOpta Inc. Toronto S.E.

Equities

SOY

CA8676EP1086

Market Closed - Toronto S.E. Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
9.16 ^CAD	+2.35%		+11.44%	+26.69%

18/04	SunOpta Brief: Says Eliminating Dividend Rights Attached to Shares of Series B-1 Preferred Stock of its subsidiary, SunOpta Foods Inc., Effective From and After December 31, 2023	MT
18/03	SunOpta Insider Sold Shares Worth $1,033,335, According to a Recent SEC Filing	MT

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.
From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Over the past four months, analysts' average price target has been revised upwards significantly.

Weaknesses

Low profitability weakens the company.
With an expected P/E ratio at 65.59 and 31.56 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
The company appears highly valued given the size of its balance sheet.
The valuation of the company is particularly high given the cash flows generated by its activity.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
For the past year, analysts have significantly revised downwards their profit estimates.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

Ratings chart - Surperformance

Sector: Food Processing

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
SUNOPTA INC.	+26.69%	792M		-
HAOXIANGNI HEALTH FOOD CO.,LTD.	-18.51%	391M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes